Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.
|Videos|February 25, 2021
Factoring Loneliness
Author(s)Inger Burnett-Zeigler, PhD
What factors make individuals more susceptible to loneliness? Gender? Race? Age?
Advertisement
Inger Burnett-Zeigler, PhD, talks about what societal and social components contribute to loneliness.
Dr Burnett-Zeigler is an associate professor of psychiatry and behavioral sciences at Northwestern University Feinberg School of Medicine, and she treats patients at the Asher Center for the Study and Treatment of Depressive Disorders.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Ozempic Dilemma: Promises and Pitfalls in Psychiatry
2
Schizophrenia: A Telltale of the Brain’s Complexity
3
Talking With Titans: Sheldon Preskorn, MD, on the Evolution of Psychopharmacology
4
Podcast: Interventional Psychiatry and the Challenge of Difficult-to-Treat Depression
5